DRI Healthcare Reports Fourth Quarter and Annual 2025 Results

TORONTO, March 3, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”) today announced its financial results for the quarter ended and year ended December 31, 2025. DRI Healthcare’s annual 2025 financial statements and Management’s Discussion & Analysis (“MD&A”) have been filed on SEDAR+ (www.sedarplus.ca). All dollar amounts are expressed in U.S. dollars unless otherwise indicated. “2025 marked […]

DRI Healthcare Trust Announces Preferred Securities Refinancing

– Refinancing extends maturity profile of existing debt by up to two years – TORONTO, March 2, 2026 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN/DHT.U) (“DRI Healthcare”)is pleased to announce that it has entered into subscription agreements with EdgePoint Wealth Management Inc., and Alberta Investment Management Corporation (AIMCo), the holders of its outstanding 7.50% Series C preferred securities […]

DRI Healthcare Reports Third Quarter 2025 Results

Subsequent to the end of the quarter, DRI Healthcare acquired a royalty interest in the U.S. net sales of veligrotug and VRDN-003, for up to $300 million Portfolio assets generated Total Income of $48.7 million Reactivated NCIB and repurchased ~394 K units for $4.1 million TORONTO, Nov. 5, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”) today announced […]

DRI Healthcare Trust Announces Acquisition of a Synthetic Royalty Interest in the U.S. Sales of Veligrotug and VRDN-003 for the Treatment of Thyroid Eye Disease (TED)

–Third synthetic royalty transaction & second pre-approval deal for DRI –– Further increases portfolio exposure to rare diseases ––  Long-dated cashflows, extend portfolio duration –– DRI Healthcare to pay US$55 million upfront; up to US$300 million total investment, subject to achievement of certain milestones– TORONTO, Oct. 20, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: […]

DRI Healthcare to Host Third Quarter 2025 Earnings Call and Webcast on November 6, 2025

TORONTO, Oct. 16, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”), a global leader in providing financing to advance innovation in the life sciences industry, announces that it will hold a conference call to discuss its third quarter 2025 financial results on Thursday, November 6, 2025, at 8:00 a.m. ET. DRI Healthcare […]

DRI Healthcare Trust Promotes Zaheed Mawani to Chief Financial Officer

TORONTO, Sept. 19, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare“) is pleased to announce the promotion of Zaheed Mawani to Chief Financial Officer, effective October 1, 2025. Mr. Mawani joined DRI Healthcare in October 2024 as Chief Compliance Officer and has been providing strategic leadership ensuring DRI Healthcare adheres to government […]

DRI Healthcare to Present at Upcoming Investor Conferences

TORONTO, Sept. 16, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”), a global leader in providing financing to advance innovation in the life sciences industry, today announced that it will present at the following investor conferences in September and October: 24th Annual CIBC Eastern Institutional Investor Conference Date: September 25, 2025Presentation […]

DRI Healthcare Reports Second Quarter 2025 Results

Subsequent to the end of the quarter, completed the previously announced transaction to internalize its investment management function Portfolio assets generate Total Income of $44.1 million Reactivated NCIB and repurchased ~958 K units for $9.1 million, while redeeming $10 million of Series C Preferred Securities for $9.5 million TORONTO, Aug. 13, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI […]

DRI Healthcare to Host Second Quarter 2025 Earnings Call and Webcast on August 14, 2025

TORONTO, July 24, 2025 /CNW/ – DRI Healthcare Trust (TSX: DHT.UN) (TSX: DHT.U) (“DRI Healthcare”), a global leader in providing financing to advance innovation in the life sciences industry, today announced that it will hold a conference call to discuss its second quarter 2025 financial results on Thursday, August 14, 2025, at 8:00 a.m. ET. The […]